Fundlater

Company announcements

leave blank for all companies
leave blank for all announcements
announcements

~ We have limited the announcement data displayed on our website to the past 12 months to ensure its accuracy and usefulness.
Search Results
Company Sector Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
Oncosil Medical Limited (OSL)
ORDINARY FULLY PAID
Health Care $16 Appendix 2A 27 Mar 2020 9:15AM $0.105 $0.520 risen by 395.24%
Oncosil Medical Limited (OSL)
ORDINARY FULLY PAID
Health Care $16 Appendix 2A 25 Mar 2020 6:45PM $0.105 $0.520 risen by 395.24%
Oncosil Medical Limited (OSL)
ORDINARY FULLY PAID
Health Care $16 Becoming and changing substantial holding 18 Mar 2020 9:24AM $0.092 $0.520 risen by 465.22%
Oncosil Medical Limited (OSL)
ORDINARY FULLY PAID
Health Care $16 FDA Grants Breakthrough Device Designation 18 Mar 2020 8:48AM $0.092 $0.520 risen by 465.22%
Oncosil Medical Limited (OSL)
ORDINARY FULLY PAID
Health Care $16 Change of Director's Interest Notice 11 Mar 2020 10:49AM $0.105 $0.520 risen by 395.24%
Oncosil Medical Limited (OSL)
ORDINARY FULLY PAID
Health Care $16 Half Yearly Report and Accounts 27 Feb 2020 8:26AM $0.135 $0.520 risen by 285.19%
Oncosil Medical Limited (OSL)
ORDINARY FULLY PAID
Health Care $16 Ceasing to be a substantial holder 21 Feb 2020 4:46PM $0.165 $0.520 risen by 215.15%
Oncosil Medical Limited (OSL)
ORDINARY FULLY PAID
Health Care $16 Change in substantial holding 18 Feb 2020 5:13PM $0.170 $0.520 risen by 205.88%
Oncosil Medical Limited (OSL)
ORDINARY FULLY PAID
Health Care $16 Appendix 4C - quarterly 30 Jan 2020 8:55AM $0.175 $0.520 risen by 197.14%
Oncosil Medical Limited (OSL)
ORDINARY FULLY PAID
Health Care $16 Change in substantial holding 24 Jan 2020 2:29PM $0.165 $0.520 risen by 215.15%
Oncosil Medical Limited (OSL)
ORDINARY FULLY PAID
Health Care $16 CE Mark Update 19 Nov 2019 8:15AM $0.210 $0.520 risen by 147.62%
Oncosil Medical Limited (OSL)
ORDINARY FULLY PAID
Health Care $16 Becoming a substantial holder 15 Nov 2019 8:17AM $0.150 $0.520 risen by 246.67%
Oncosil Medical Limited (OSL)
ORDINARY FULLY PAID
Health Care $16 Positive CE Mark Status Report 1 Nov 2019 9:15AM $0.105 $0.520 risen by 395.24%
Oncosil Medical Limited (OSL)
ORDINARY FULLY PAID
Health Care $16 Appendix 4C - quarterly 31 Oct 2019 9:26AM $0.100 $0.520 risen by 420%
Oncosil Medical Limited (OSL)
ORDINARY FULLY PAID
Health Care $16 Results of Meeting 29 Oct 2019 1:22PM $0.123 $0.520 risen by 324.49%
Oncosil Medical Limited (OSL)
ORDINARY FULLY PAID
Health Care $16 OncoSil AGM CEO Presentation 29 Oct 2019 8:34AM $0.115 $0.520 risen by 352.17%
Oncosil Medical Limited (OSL)
ORDINARY FULLY PAID
Health Care $16 Updated Clinical Evaluation Report to BSI 28 Oct 2019 7:39PM $0.115 $0.520 risen by 352.17%
Oncosil Medical Limited (OSL)
ORDINARY FULLY PAID
Health Care $16 Receipt of $3.8M R&D Tax Incentive 18 Oct 2019 9:03AM $0.094 $0.520 risen by 453.19%
Oncosil Medical Limited (OSL)
ORDINARY FULLY PAID
Health Care $16 Positive Regulatory Updates 11 Oct 2019 9:35AM $0.065 $0.520 risen by 700%
Oncosil Medical Limited (OSL)
ORDINARY FULLY PAID
Health Care $16 Changes in Senior Management 30 Sep 2019 9:29AM $0.064 $0.520 risen by 712.50%
Oncosil Medical Limited (OSL)
ORDINARY FULLY PAID
Health Care $16 2019 Annual Report 27 Sep 2019 9:53AM $0.064 $0.520 risen by 712.50%
Oncosil Medical Limited (OSL)
ORDINARY FULLY PAID
Health Care $16 2019 Notice of General Meeting & Proxy Form 27 Sep 2019 9:53AM $0.064 $0.520 risen by 712.50%
Oncosil Medical Limited (OSL)
ORDINARY FULLY PAID
Health Care $16 2019 Appendix 4G and Corporate Governance Statement 27 Sep 2019 9:47AM $0.064 $0.520 risen by 712.50%
Oncosil Medical Limited (OSL)
ORDINARY FULLY PAID
Health Care $16 Change of Director's Interest Notice - Amended 11 Sep 2019 8:48AM $0.085 $0.520 risen by 511.76%
Oncosil Medical Limited (OSL)
ORDINARY FULLY PAID
Health Care $16 Change of Director's Interest Notice - Amended 11 Sep 2019 8:47AM $0.085 $0.520 risen by 511.76%

501 - 525 of 759 results

Page 21 of 31

  • + Company announcements and prices are delayed by at least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.